PhD candidate at the Leiden University Medical Center (LUMC), Netherlands. The focus of my project is the development and validation of a tumor biomarker to identify patients with gynecologic cancers who could benefit from treatment with PARP inhibitors.
PhD candidate at the Leiden University Medical Center (LUMC), Netherlands. The focus of my project is the development and validation of a tumor biomarker to identify patients with gynecologic cancers who could benefit from treatment with PARP inhibitors.